v3.25.4
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2025
STOCKHOLDERS' EQUITY  
Schedule of restricted stock unit activity

Weighted Average

  ​ ​ ​

Amount

  ​ ​ ​

Grant Date Fair Value

Outstanding at December 31, 2023

532,399

$

14.82

Granted

1,148,201

 

7.07

Forfeited

(78,986)

 

14.66

Vested

(221,337)

 

14.90

Outstanding at December 31, 2024

1,380,277

$

8.38

Granted

1,533,722

 

6.03

Forfeited

(101,484)

 

8.62

Vested

(326,764)

10.30

Expired

(10,404)

16.02

Outstanding at December 31, 2025

2,475,347

$

6.63

Schedule of options granted

  ​ ​ ​

Grant Date

August 6, 2025

August 1, 2025

July 1, 2024

June 7, 2024

Risk-free interest rate

3.77%

3.77%

4.44%

4.42%

Expected volatility of common stock

43.56%

43.56%

50.03%

50.04%

Dividend yield

-

-

-

-

Expected option term in years

6.0

6.0

6.0

6.0

Grant-date fair value (per share)

$ 2.92

$ 2.80

$ 3.46

$ 3.73

Schedule of stock options activity

  ​ ​ ​

Amount

  ​ ​ ​

Weighted Average Exercise Price per Share

  ​ ​ ​

Weighted Average Remaining Contractual Life (Years)

  ​ ​ ​

Aggregate Intrinsic Value
(in thousands) (1)

Outstanding at December 31, 2023

-

$

-

-

$

-

Granted

646,301

7.02

9.44

-

Forfeited

-

-

-

-

Outstanding at December 31, 2024

646,301

$

7.02

9.44

$

-

Granted

763,485

6.08

-

788

Forfeited

(38,646)

7.02

-

3

Expired

(32,205)

7.02

-

3

Outstanding at December 31, 2025

1,338,935

$

6.48

9.01

$

839

Exercisable at December 31, 2025

191,811

$

7.02

8.44

$

20,459

Exercisable at December 31, 2024

-

$

-

-

$

-

(1)Total shares valued at the market price of the underlying stock as of December 31, 2025 less the exercise price.